Setting the standard for telehealth We meet the highest regulatory standards, giving you confidence when it matters most
Study Population and Baseline Characteristics The researchers identified 932 T2D patients who had at least two dispensings of oral semaglutide between 2020 and 2022
Some individuals may be more sensitive to the medication and require a smaller, more gradual increase in dosage to manage side effects
Think of it like a kitchen drain that has been partially blocked: water still flows, but the backup creates pressure above the blockage
Defying fears of losing significant market share to generics, innovators Novo Nordisk and Eli Lilly, along with their domestic partners Cipla, Emcure, and Abbott, have continued to show steady month-on-month growth, indicating a loyal prescriber base and patient onboarding